• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCL6原癌基因抑制生发中心B细胞中的p53表达。

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

作者信息

Phan Ryan T, Dalla-Favera Riccardo

机构信息

Institute for Cancer Genetics and the Department of Pathology, Columbia University, New York, New York 10032, USA.

出版信息

Nature. 2004 Dec 2;432(7017):635-9. doi: 10.1038/nature03147.

DOI:10.1038/nature03147
PMID:15577913
Abstract

The human proto-oncogene BCL6 encodes a BTB/POZ-zinc-finger transcriptional repressor that is necessary for germinal-centre formation and is implicated in the pathogenesis of B-cell lymphoma. The precise function of BCL6 in germinal-centre development and lymphomagenesis is unclear because very few direct BCL6 target genes have been identified. Here we report that BCL6 suppresses the expression of the p53 (also known as tp53) tumour suppressor gene and modulates DNA damage-induced apoptotic responses in germinal-centre B cells. BCL6 represses p53 transcription by binding two specific DNA sites within the p53 promoter region and, accordingly, p53 expression is absent in germinal-centre B cells where BCL6 is highly expressed. Suppression of BCL6 expression via specific short interfering RNA leads to increased levels of p53 messenger RNA and protein both under basal conditions and in response to DNA damage. Most notably, constitutive expression of BCL6 protects B cell lines from apoptosis induced by DNA damage. These results suggest that an important function of BCL6 is to allow germinal-centre B cells to tolerate the physiological DNA breaks required for immunoglobulin class switch recombination and somatic hypermutation without inducing a p53-dependent apoptotic response. These findings also imply that deregulated BCL6 expression contributes to lymphomagenesis in part by functional inactivation of p53.

摘要

人类原癌基因BCL6编码一种BTB/POZ-锌指转录抑制因子,它是生发中心形成所必需的,并且与B细胞淋巴瘤的发病机制有关。由于很少有直接的BCL6靶基因被鉴定出来,因此BCL6在生发中心发育和淋巴瘤发生中的精确功能尚不清楚。在此,我们报告BCL6抑制p53(也称为tp53)肿瘤抑制基因的表达,并调节生发中心B细胞中DNA损伤诱导的凋亡反应。BCL6通过结合p53启动子区域内的两个特定DNA位点来抑制p53转录,因此,在BCL6高表达的生发中心B细胞中不存在p53表达。通过特异性短干扰RNA抑制BCL6表达会导致在基础条件下以及对DNA损伤作出反应时p53信使RNA和蛋白质水平升高。最值得注意的是,BCL6的组成型表达可保护B细胞系免受DNA损伤诱导的凋亡。这些结果表明,BCL6的一个重要功能是使生发中心B细胞能够耐受免疫球蛋白类别转换重组和体细胞超突变所需的生理性DNA断裂,而不诱导p53依赖性凋亡反应。这些发现还意味着BCL6表达失调部分通过p53的功能失活促成淋巴瘤发生。

相似文献

1
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.BCL6原癌基因抑制生发中心B细胞中的p53表达。
Nature. 2004 Dec 2;432(7017):635-9. doi: 10.1038/nature03147.
2
Acetylation inactivates the transcriptional repressor BCL6.乙酰化使转录抑制因子BCL6失活。
Nat Genet. 2002 Dec;32(4):606-13. doi: 10.1038/ng1018. Epub 2002 Oct 28.
3
BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.BCL6与转录因子Miz-1相互作用,以抑制生发中心B细胞中的细胞周期蛋白依赖性激酶抑制剂p21并阻止细胞周期。
Nat Immunol. 2005 Oct;6(10):1054-60. doi: 10.1038/ni1245. Epub 2005 Sep 4.
4
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.PU.1蛋白表达与生发中心B细胞基因(包括BCL-6、CD10、CD20和CD22)的蛋白表达呈正线性关联:在BCL-6启动子中鉴定PU.1假定结合位点。
J Pathol. 2005 Jul;206(3):312-9. doi: 10.1002/path.1777.
5
The proto-oncogene BCL-6 in normal and malignant B cell development.原癌基因BCL-6在正常和恶性B细胞发育中的作用
Hematol Oncol. 2002 Dec;20(4):155-66. doi: 10.1002/hon.689.
6
The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.白细胞介素-21受体基因是弥漫性大B细胞淋巴瘤中经常出现的t(3;16)(q27;p11)中BCL6的伙伴基因。
Oncogene. 2002 Jan 17;21(3):368-76. doi: 10.1038/sj.onc.1205099.
7
The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.LAZ3/BCL6癌基因编码一种序列特异性转录抑制剂:BTB/POZ结构域作为自主抑制结构域的新功能。
Cell Growth Differ. 1995 Dec;6(12):1495-503.
8
Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.BCL6原癌基因的靶向体细胞突变及其对淋巴瘤发生的影响。
Hematology. 2005 Apr;10(2):115-29. doi: 10.1080/10245330400026105.
9
Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.前B细胞白血病转录因子1是早幼粒细胞白血病锌指蛋白介导的黑色素瘤细胞生长抑制的主要靶点。
Oncogene. 2007 Jan 18;26(3):339-48. doi: 10.1038/sj.onc.1209800. Epub 2006 Jul 24.
10
BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.BCL6:生发中心反应的主要调节因子和 B 细胞淋巴瘤发生的关键癌基因。
Adv Immunol. 2010;105:193-210. doi: 10.1016/S0065-2776(10)05007-8.

引用本文的文献

1
AR to GR switch modulates differential TDO2-Kyn-AhR signalling to promote the survival and recurrence of treatment-induced dormant cells in prostate cancer.雄激素受体(AR)向糖皮质激素受体(GR)的转换调节TDO2-犬尿氨酸-芳香烃受体(AhR)的差异信号传导,以促进前列腺癌中治疗诱导的休眠细胞的存活和复发。
Cell Discov. 2025 Aug 5;11(1):67. doi: 10.1038/s41421-025-00817-w.
2
Unveiling vitamin C: A new hope in the treatment of diffuse large B‑cell lymphoma (Review).揭示维生素C:弥漫性大B细胞淋巴瘤治疗的新希望(综述)
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5746. Epub 2025 May 2.
3
A Bivalent Molecular Glue Linking Lysine Acetyltransferases to Oncogene-induced Cell Death.
一种将赖氨酸乙酰转移酶与癌基因诱导的细胞死亡联系起来的双价分子胶。
bioRxiv. 2025 Mar 17:2025.03.14.643404. doi: 10.1101/2025.03.14.643404.
4
Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies.惰性B细胞恶性肿瘤向侵袭性B细胞恶性肿瘤转变的分子机制
Cancers (Basel). 2025 Mar 6;17(5):907. doi: 10.3390/cancers17050907.
5
BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.BCL6(B细胞淋巴瘤6)在子宫腺肌病、平滑肌瘤和正常子宫肌层中的表达。
PLoS One. 2025 Feb 4;20(2):e0317136. doi: 10.1371/journal.pone.0317136. eCollection 2025.
6
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis.B细胞淋巴瘤/白血病11A在正常和恶性造血中的作用。
Biology (Basel). 2025 Jan 1;14(1):26. doi: 10.3390/biology14010026.
7
Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment.内在的p53激活在潜伏期建立过程中限制γ疱疹病毒驱动的生发中心B细胞扩增。
Nat Commun. 2025 Jan 22;16(1):951. doi: 10.1038/s41467-025-56247-5.
8
Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth.白藜芦醇作为一种BCL6天然抑制剂可抑制生发中心来源的非霍奇金淋巴瘤细胞生长。
J Nat Med. 2025 Mar;79(2):399-411. doi: 10.1007/s11418-024-01873-4. Epub 2025 Jan 15.
9
B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond.B 细胞淋巴瘤因子 6(BCL6):免疫调节的保守调控因子及其它功能。
Int J Mol Sci. 2024 Oct 11;25(20):10968. doi: 10.3390/ijms252010968.
10
B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.B 细胞分化与人类 B 细胞淋巴瘤的起源和发病机制。
Methods Mol Biol. 2025;2865:1-30. doi: 10.1007/978-1-0716-4188-0_1.